Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Reference33 articles.
1. Qasim W, Brunetto M, Gehring A, Xue SA, Schurich A, Khakpoor A et al (2014) Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells targeting HBsAg in a liver transplant patient. J Hepatol. doi: 10.1016/j.jhep.2014.10.001
2. Ringelhan M, Protzer U, O’Connor T, Heikenwalder M (2014) The direct and indirect role of HBV in liver cancer: prospective markers for HCC-screening and potential therapeutic targets. J Pathol. doi: 10.1002/path.4434
3. Palmer DH, Hussain SA, Smith AJ, Hargreaves S, Ma YT, Hull D et al (2013) Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom. Br J Cancer 109(4):888–890. doi: 10.1038/bjc.2013.410
4. Printz C (2009) Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM). Cancer 115(20):4646. doi: 10.1002/cncr.24673
5. Mori M, Triboulet R, Mohseni M, Schlegelmilch K, Shrestha K, Camargo FD et al (2014) Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell 156(5):893–906. doi: 10.1016/j.cell.2013.12.043
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献